Good morning, it's Paul & Jack here with the SCVR for Tuesday.

A quick reminder, can people please remember to put the company name or ticker in your comments. We're still getting orphan comments, where e.g. people say how much they like the company. The trouble is, many readers won't know which company you're referring to, so the comment is completely wasted. Maybe there's only one company in the article when you leave the comment, but please remember more sections are added during the morning, Thanks.

Agenda -

Paul's Section:

Electra Private Equity (LON:ELTA) - it's demerger day! ELTA shares now become just Hotter Shoes, and ELTA shareholders will receive newly listed Hostmore (ticker: MORE) shares, 3 for every 1 ELTA share. Now the market will decide how much each company is worth separately. Expect considerable short term volatility.

Jack's section:

Warpaint London (LON:W7L) - continuation of improving trends and FY results expected to be ahead of expectations. Strong momentum here after a couple of setbacks, and the founders and major shareholders remain in charge, so worth assessing the longer term prospects.

Up Global Sourcing Holdings (LON:UPGS) - supply chain issues are being mitigated and the growth prospects continue to look attractive. The recent moderation in sentiment means you can buy a growing company with a forecast dividend yield approaching 4%.


Explanatory notes -

A quick reminder that we don’t recommend any stocks. We aim to cover trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.

We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).

A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed - please be civil, rational, and include the company name/ticker, otherwise people won't necessarily know what company you are referring to.


Paul’s Section:

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here